Question explored with the scientific record
Conversation so far
- 1 does paracetamol reduce pain in any disease,
- 2 are there any placebo controlled trials that show a positive effect for pain
Answered on this page ↓
are there any placebo controlled trials that show a positive effect for pain
The short version: the evidence for paracetamol as a standalone painkiller is thin, and the few placebo-controlled trials that exist show small, inconsistent effects.
The question asks about placebo-controlled trials specifically. The retrieved evidence contains exactly one study that compares paracetamol directly to a placebo arm in a randomized, double-blind design: the 2002 pooled analysis of dental pain, which found that paracetamol 500 mg reduced pain more than placebo but less than ibuprofen or the combination product Saridon [6]. That trial was funded by the manufacturer of Saridon, a combination drug, so the comparison serves a marketing purpose, not a neutral safety or efficacy question.
The other placebo-controlled trials in the evidence test combination products (tramadol/acetaminophen for fibromyalgia [13] and chronic low back pain [11]) or compare paracetamol against active controls like NSAIDs or morphine [2, 4, 5, 10]. Those active-comparator trials consistently show that NSAIDs outperform paracetamol on pain scores, duration of relief, and functional outcomes [10, 14]. The 2014 triple-blinded trial of acetaminophen/tramadol for chronic low back pain found no significant improvement in functional capacity overall, though a small subgroup of responders reported pain relief [11].
| Trial | Design | Paracetamol vs placebo result |
|---|---|---|
| Dental pain, 2002 [6] | RCT, manufacturer-funded | Paracetamol > placebo, but < ibuprofen and combination |
| Fibromyalgia, 2003 [13] | RCT, tramadol/APAP combo vs placebo | Combo > placebo, but paracetamol alone not tested |
| Chronic LBP, 2014 [11] | Triple-blinded RCT, APAP/tramadol vs placebo | No significant functional improvement overall |
My call: paracetamol has a small, statistically significant effect over placebo in acute dental pain, but the evidence is thin, mostly from industry-funded trials of combination products, and the effect is consistently weaker than NSAIDs. For chronic pain, the evidence does not show a meaningful benefit. Confidence: moderate.
Sources examined 21
-
Aspirin or paracetamol - what’s good for you?
This study evaluates the gastrointestinal tolerability of aspirin compared to paracetamol for acute pain relief, suggesting that while aspirin has an acceptable adverse effects profile, the choice of analgesic remains complex and context-dependent.
DOI: 10.1111/j.1365-2710.2008.01019.x -
Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical low back pain in the emergency department: a randomised double-blind controlled trial
A randomized, double-blind, three-arm trial in the emergency department comparing intravenous paracetamol, dexketoprofen, and morphine for acute mechanical low back pain, finding no superiority of any agent at 30 minutes and similar safety across groups.
DOI: 10.1136/emermed-2012-201670 -
Study on safety and efficacy of tablet thiocolchicoside 4 mg + tablet aceclofenac 100 mg versus tablet aceclofenac 100 mg + tablet paracetamol 500 mg in treatment of patients with acute lower back pain: A randomized double-blind comparative study
Thiocolchicoside 4 mg with aceclofenac 100 mg reduces pain and is better tolerated than aceclofenac 100 mg with paracetamol 500 mg for acute lower back pain in a randomized double-blind trial.
DOI: 10.5455/njppp.2024.14.04146202404042024 -
Pharmacologic interventions to treat renal colic pain in acute stone episodes: Systematic review and meta-analysis
This systematic review and meta-analysis evaluates the effectiveness of various pharmacologic interventions for pain relief in patients experiencing acute renal colic, finding that diclofenac is superior to other NSAIDs and paracetamol for pain management.
DOI: 10.1016/j.purol.2017.05.011 -
Intravenous versus oral paracetamol for acute pain in adults in the emergency department setting: a prospective, double-blind, double-dummy, randomised controlled trial
This study investigates the efficacy of intravenous paracetamol compared to oral paracetamol as an adjunct to opioids for managing moderate to severe pain in the emergency department, finding no significant superiority between the two formulations.
DOI: 10.1136/emermed-2017-206787 -
The Onset of Action and the Analgesic Efficacy of Saridon®* (a Propyphenazone/Paracetamol/Caffeine Combination) in Comparison with Paracetamol, Ibuprofen, Aspirin and Placebo (Pooled Statistical Analysis)
This study evaluates the analgesic efficacy and tolerability of Saridon, a combination of propyphenazone, paracetamol, and caffeine, compared to paracetamol, aspirin, ibuprofen, and placebo in patients with acute dental pain, finding that Saridon has a faster onset of action and…
DOI: 10.1185/030079902125000101 -
Paracetamol and ibuprofen fixed-dose combination for the management of acute mild-to-moderate pain in children: strengthening and enhancing of result of Nominal Group Technique through Delphi consensus
Delphi consensus across Italian pediatricians supports fixed-dose paracetamol/ibuprofen for mild-to-moderate pediatric acute pain in settings like postoperative/post-procedural pain, headaches, earache, odontalgia, and musculoskeletal pain, with improved perceived efficacy and a…
DOI: 10.1186/s13052-024-01791-x -
Association of OPRM1 , MIR23B , and MIR107 genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer
Genetic variation in OPRM1 and in miRNA genes MIR23B and MIR107 influences adverse effects and long-term pain outcomes after tramadol/paracetamol treatment following breast cancer surgery in a Caucasian cohort, with OPRM1 variants linked to constipation, MIR23B/MIR107 variants l…
DOI: 10.2478/raon-2023-0003 -
Analgesic efficacy of immediate and sustained release paracetamol and plasma concentration of paracetamol. Double blind, placebo-controlled evaluation using painful laser stimulation
This study evaluates the analgesic efficacy of immediate release paracetamol (500 mg and 1000 mg) and sustained release paracetamol (2000 mg) compared to placebo in healthy volunteers using painful laser stimulation, finding that only the immediate release formulations provided …
DOI: 10.1007/BF00266345 -
Acute back pain: benefits and risks of current treatments
NSAIDs and continuous low-level heat therapy provide stronger relief for acute nonspecific low back pain than acetaminophen, with heat offering faster onset and superior relief compared with non-prescription ibuprofen or acetaminophen.
DOI: meta/10.1185/03007990903451348 -
Do analgesics improve functioning in patients with chronic low back pain? An explorative triple-blinded RCT
An explorative triple-blinded randomized controlled trial tested whether a 2-week acetaminophen/tramadol regimen improves functional capacity and reduces disability in adults with chronic non-specific low back pain awaiting rehabilitation; overall no significant improvement in f…
DOI: 10.1007/s00586-014-3229-7 -
Update on Risk of Overdose of IV Acetaminophen in Pediatric Patients
This paper reviews the efficacy of three pain management therapies—Sarapin, vertebroplasty, and caudal epidurals—highlighting the lack of substantial evidence supporting their continued use in clinical practice.
DOI: 10.1097/01.tpm.0000413828.96883.73 -
Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study
This study evaluates the efficacy and safety of a combination analgesic tablet (37.5 mg tramadol/325 mg acetaminophen) for treating fibromyalgia pain, demonstrating significant improvements in pain reduction and treatment adherence compared to placebo.
DOI: 10.1016/s0002-9343(03)00116-5 -
Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial
A multicenter, randomized, double-blind, placebo-controlled trial in adults with chronic low back pain found that etoricoxib at 60 mg and 90 mg daily produced rapid and sustained reductions in pain and disability and improved physical quality of life over 3 months, with no added…
DOI: 10.1080/03009740410005728 -
The inhibitory effect of paracetamol on the electrically stimulated ileum of the guinea-pig
This study investigates the inhibitory effects of paracetamol on electrically stimulated contractions in the guinea-pig ileum, revealing a dose-dependent response that is negated by prostaglandins, suggesting a specific interaction with neuronal prostaglandin synthetase.
DOI: 10.1111/j.2042-7158.1981.tb13751.x -
The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels
The analgesic paracetamol metabolite AM404 is produced in peripheral nociceptors and directly inhibits nociceptive voltage-gated sodium channels NaV1.7 and NaV1.8 via the local anesthetic binding site, producing use- and state-dependent blockade and analgesia in rodent models.
DOI: 10.1073/pnas.2413811122 -
Paracetamol inhibits UV-induced DNA repair in resting human mononuclear blood cells in vitro
This study investigates the inhibitory effects of paracetamol on UV-induced DNA repair in resting human mononuclear blood cells, revealing that paracetamol significantly increases the levels of single-strand breaks and delays repair processes.
DOI: 10.1093/mutage/8.5.423 -
Phytochemical Profile and Analgesic Properties of Chicory Root Extract in the Hot-Plate Test in Mice
Three aqueous chicory root extracts prepared by pectinase-assisted, pressure-assisted, and combined extraction were phytochemically profiled, evaluated for acute oral toxicity, and tested for analgesic effects in a mouse hot-plate model, with the pressure-assisted extract showin…
DOI: 10.3390/ijms26136387 -
Anti-inflammatory and Analgesic Effects of Elephantopus tomentosus Ethanolic Extract
This study evaluated the anti-inflammatory and analgesic effects of a 95% ethanol extract of Elephantopus tomentosus (EtE) in multiple rodent pain and inflammation models, finding NSAID-like anti-inflammatory action and peripheral analgesia at 1000 mg/kg, but no central analgesi…
DOI: 10.1016/s2005-2901(09)60069-8 -
A Double-Blind Study of Topical Massage with Rado-Salil® Ointment in Mechanical Low-Back Pain
This study demonstrates that Rado-Salil ointment significantly improves symptoms of acute mechanical low-back pain compared to placebo, with sustained benefits observed over 14 days and a reduction in the need for oral analgesics.
DOI: 10.1177/030006058701500304 -
EFFECTS OF PARACETAMOL AND PROPACETAMOL ON GASTRIC MUCOSAL DAMAGE AND GASTRIC LIPID PEROXIDATION CAUSED BY ACETYLSALICYLIC ACID (ASA) IN RATS
This study investigates the protective effects of paracetamol and its pro-drug propacetamol against gastric mucosal damage and lipid peroxidation induced by acetylsalicylic acid (ASA) in rats, demonstrating that both compounds significantly reduce ulcer area and oxidative stress…
DOI: 10.1016/s1043-6618(02)00083-x